# Grupo Aval Acciones Y Valores S.A.: overview AVAL · NYSE · CIK 1504764 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aval.md) · [Financials](/companies/aval/financials.md) · [Filings](/companies/aval/filings.md) · [Insiders](/companies/aval/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [38,468](/filings/0001558370-23-005915.md) | [39,064](/filings/0001558370-24-005220.md) | [37,275](/filings/0001558370-25-005663.md) | [47,658](/filings/0001558370-25-005663.md) | [46,493](/filings/0001558370-25-005663.md) | | Gross margin | % | [7.3%](/filings/0001558370-23-005915.md) | [7.9%](/filings/0001558370-24-005220.md) | [12.2%](/filings/0001558370-25-005663.md) | [6.8%](/filings/0001558370-25-005663.md) | [5.3%](/filings/0001558370-25-005663.md) | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [105.45](/filings/0001558370-23-005915.md) | [148.01](/filings/0001558370-24-005220.md) | [107.29](/filings/0001558370-25-005663.md) | [31.12](/filings/0001558370-25-005663.md) | [42.75](/filings/0001558370-25-005663.md) | | Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL not reported. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aval/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Truffle Hound Capital, LLC](/funds/1595862.md) | 2026-06-30 | $5.0m | 1,000,000 | | Reduced −400,000 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $4.4m | 865,172 | | Reduced −30,600 | | [Pekin Hardy Strauss, Inc.](/funds/1020317.md) | 2026-06-30 | $2.6m | 517,050 | | Added +23,200 | | [Banco BTG Pactual S.A.](/funds/1536080.md) | 2026-06-30 | $1.1m | 226,559 | | Added +91,238 | | [Stokes Family Office, LLC](/funds/1802278.md) | 2026-06-30 | $1.1m | 210,123 | | Added +934 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $948.9k | 188,639 | | New +188,639 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $736.0k | 146,322 | | Added +124,278 | | [O'Brien Greene & Co. Inc](/funds/1768635.md) | 2026-06-30 | $628.8k | 125,000 | | New +125,000 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $597.8k | 118,855 | | Added +29,179 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $594.7k | 117,794 | | Reduced −14,825 | ## Recent filings [All 551 filings](/companies/aval/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:05 ET | [6-K](/filings/0000950103-26-016246.md) | Report of a foreign private issuer, period 2026-10-27 | 0000950103-26-016246 | | 2026-10-01 | 17:08 ET | [6-K](/filings/0000950103-26-014957.md) | Report of a foreign private issuer, period 2026-10-01 | 0000950103-26-014957 | | 2026-09-29 | 19:54 ET | [6-K](/filings/0000950103-26-014648.md) | Report of a foreign private issuer, period 2026-09-28 | 0000950103-26-014648 | | 2026-09-15 | 18:58 ET | [6-K](/filings/0000950103-26-013936.md) | Report of a foreign private issuer, period 2026-09-14 | 0000950103-26-013936 | | 2026-09-02 | 16:17 ET | [6-K](/filings/0000950103-26-013486.md) | Report of a foreign private issuer, period 2026-09-02 | 0000950103-26-013486 | | 2026-08-26 | 16:04 ET | [6-K](/filings/0000950103-26-012925.md) | Report of a foreign private issuer, period 2026-08-26 | 0000950103-26-012925 | | 2026-08-25 | 19:57 ET | [6-K](/filings/0000950103-26-012816.md) | Report of a foreign private issuer, period 2026-08-24 | 0000950103-26-012816 | | 2026-08-17 | 20:30 ET | [6-K](/filings/0000950103-26-012456.md) | Report of a foreign private issuer, period 2026-08-14 | 0000950103-26-012456 | | 2026-08-17 | 19:21 ET | [6-K](/filings/0000950103-26-012454.md) | Report of a foreign private issuer, period 2026-08-14 | 0000950103-26-012454 | | 2026-08-14 | 16:04 ET | [6-K](/filings/0000950103-26-012425.md) | Report of a foreign private issuer, period 2026-08-14 | 0000950103-26-012425 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-044493.md), filed Apr 17, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1504764 - Tickers: AVAL - Exchange: NYSE - SIC code: 6029 Commercial Banks, NEC - State of incorporation: not reported - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:07 ET. No prices; not investment advice.